KOE:039840

DIO Corporation · KOE · Healthcare · KRW · FY for 2025

Figures on this page computed 2026-11-08 12:46 UTC

Last close

n/aKRW

Market data

  • n/aP/E

    We do not hold this figure for this company, so there is nothing to place.

    Price / Earnings per Share (diluted)

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    KRW
    • computed
    • Computed from the filing for 2025
  • 0.9%ROIC

    NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    KRW
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • -0.8%Net margin

    Net Income / Revenue x 100

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    KRW
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • 7.2%FCF margin

    Free Cash Flow / Revenue x 100

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    KRW
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • 0.42Debt/equity

    Total Debt / Shareholders' Equity

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    KRW
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • n/aDividend yield

    We do not hold this figure for this company, so there is nothing to place.

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    KRW
    • computed

Five bars, one line

lens 7 of 9
1.32x
-0.38x
-4.18x
1.05x
n/a
SalesProfitFree cash flowDebtPrice
Each bar against this company's own average; the line is that average.
Computed2025
Computed2025
Computed2025
Computed2025
Market datan/a

Each against its own average

4 of 5 read

Except where said otherwise: Computed from the filing for 2025

  • Sales1.32x

    Its own average over 10 years, 123.91B.

  • Profit-0.38x

    Its own average over 10 years, 3.58B.

  • Free cash flow-4.18x

    Its own average over 10 years, -2.81B.

  • Debt1.05x

    Its own average over 10 years, 77.30B.

  • Pricen/a

    Its own average over 0 years. Market data

Free cash flow is furthest from its own average, at -4.18 times.

Sales is 1.32 times its own 10-year average; Profit is -0.38 times its own 10-year average; Free cash flow is -4.18 times its own 10-year average; Debt is 1.05 times its own 10-year average.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

  • Sales against its own 10-year average1.32
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    KRW
  • Profit against its own 10-year average-0.38
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    KRW
  • Free cash flow against its own 10-year average-4.18
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    KRW
  • Debt against its own 10-year average1.05
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    KRW
  • Price against its own 0-year averagen/aMarket data

    Not held.

    Source
    market
    Reported in
    KRW

Filed figures cite the filing they come from; figures marked Market data are quotes as of the date shown. Not a recommendation and not advice.

Past figures are not a forecast. Anything we modelled is labelled as ours. You can lose money on any security.